Before the Bell Scans: Vertex Pharma Inc., MAKO Surgical Corp., Alere Inc., and Orexigen Therapeutics Inc.

 Before the Bell Scans: Vertex Pharma Inc., MAKO Surgical Corp., Alere Inc.,
                        and Orexigen Therapeutics Inc.

PR Newswire

LONDON, November 13, 2013

LONDON, November 13, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Tuesday, November 12, 2013, the S&P 500 ended the day at 1,767.69, down
0.24%; the Dow Jones Industrial Average closed at 15,750.67, down 0.21%; and
the NASDAQ Composite finished nearly flat at 3,919.92. Shares in the
healthcare sector fluctuated between gains and losses, even as the broader
market declined. The major movers in the sector included Vertex
Pharmaceuticals Inc. (NASDAQ: VRTX), MAKO Surgical Corp. (NASDAQ: MAKO), Alere
Inc. (NYSE: ALR), and Orexigen Therapeutics Inc. (NASDAQ: OREX). All these
companies are tracked by AAAResearchReports.com. Free technical research on
VRTX, MAKO, ALR, and OREX can be downloaded upon signing up at:

http://www.aaaresearchreports.com/register/ 

Vertex Pharmaceuticals Inc.'s shares edged lower by 0.61% on Tuesday, tracking
losses in the broader market. The company's shares closed at$60.18 after
oscillating between$58.06 and$60.56 during the trading session. A total of
3.61 million shares were traded, which is above the daily average volume of
2.43 million. The company's shares have lost 1.38% in the previous three
trading sessions, underperforming the S&P 500, which has gained 1.18% during
the same period. Furthermore, Vertex Pharmaceuticals Inc.'s stock is trading
below its 50-day and 200-day moving averages of $74.36 and $70.07,
respectively. Sign up today to read free research report on VRTX at:

http://www.AAAResearchReports.com/VRTX111313.pdf

MAKO Surgical Corp.'s shares traded between $29.78 and $29.93 before finishing
the Tuesday's session 0.07% higher at $29.92. A total of 0.82 million shares
were traded, which is below the daily average volume of 1.94 million. The
company's shares have rallied 101.35% in the previous three months, compared
to a gain of 4.63% in the S&P 500 during the same period. Moreover, MAKO
Surgical Corp.'s stock is trading near its 52-week high of $29.94 and also
above its 50-day and 200-day moving averages of $25.39 and $15.45,
respectively. Register to download free technical analysis on MAKO at:

http://www.AAAResearchReports.com/MAKO111313.pdf

On Tuesday, shares in Alere Inc. closed the day at $33.57, down 0.80% from the
previous day's closing price of $33.84. The company's shares vacillated
between $33.39 and $33.75 during the trading session. A total of 0.23 million
shares were traded, which is below the daily average volume of 0.55 million.
Despite Tuesday's losses, the company's shares have gained 6.71% in the last
one month and 4.84% in the previous three months, outperforming the S&P 500,
which has gained 3.79% and 4.63% during the respective periods. Further, Alere
Inc.'s stock is currently trading above its 50-day and 200-day moving averages
of $32.00 and $27.65, respectively. A free report on ALR can be accessed by
registering at:

http://www.AAAResearchReports.com/ALR111313.pdf

Orexigen Therapeutics Inc.'s shares rallied 5.54% on Tuesday, finishing the
day at$5.33 after fluctuating between$5.00 and $5.38 during the trading
session. A total of 1.46 million shares were traded, which is above the daily
average volume of 1.07 million. The company's stock has surged 12.92% in the
previous three trading sessions, compared to a gain of 1.18% in the S&P 500
during the same period. However, Orexigen Therapeutics Inc.'s shares are
trading below their 50-day and 200-day moving averages of $5.96 and $6.19,
respectively. Register with AAA Research Reports and download the research on
OREX for free at:

http://www.AAAResearchReports.com/OREX111313.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE AAA Research Reports

Contact: + 1 (646) 396-9126 : Peter F. Jones : info@aaaresearchreports.com